{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T21:01:18Z","timestamp":1768251678949,"version":"3.49.0"},"reference-count":127,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,8,30]],"date-time":"2017-08-30T00:00:00Z","timestamp":1504051200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,8,30]],"date-time":"2017-08-30T00:00:00Z","timestamp":1504051200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R21EY027065"],"award-info":[{"award-number":["R21EY027065"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s00018-017-2635-5","type":"journal-article","created":{"date-parts":[[2017,8,30]],"date-time":"2017-08-30T14:11:04Z","timestamp":1504102264000},"page":"635-647","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Secretogranin III: a diabetic retinopathy-selective angiogenic factor"],"prefix":"10.1007","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9566-8764","authenticated-orcid":false,"given":"Wei","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith A.","family":"Webster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle E.","family":"LeBlanc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,30]]},"reference":[{"issue":"9","key":"2635_CR1","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1523\/JNEUROSCI.10-09-03135.1990","volume":"10","author":"HP Ottiger","year":"1990","unstructured":"Ottiger HP, Battenberg EF, Tsou AP, Bloom FE, Sutcliffe JG (1990) 1B1075: a brain- and pituitary-specific mRNA that encodes a novel chromogranin\/secretogranin-like component of intracellular vesicles. J Neurosci 10(9):3135\u20133147","journal-title":"J Neurosci"},{"issue":"4","key":"2635_CR2","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/BF02821554","volume":"4","author":"A Dopazo","year":"1993","unstructured":"Dopazo A, Lovenberg TW, Danielson PE, Ottiger HP, Sutcliffe JG (1993) Primary structure of mouse secretogranin III and its absence from deficient mice. J Mol Neurosci 4(4):225\u2013233. doi: 10.1007\/BF02821554","journal-title":"J Mol Neurosci"},{"issue":"4","key":"2635_CR3","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1084\/jem.20161802","volume":"214","author":"ME LeBlanc","year":"2017","unstructured":"LeBlanc ME, Wang W, Chen X, Caberoy NB, Guo F, Shen C et al (2017) Secretogranin III as a disease-associated ligand for antiangiogenic therapy of diabetic retinopathy. J Exp Med 214(4):1029\u20131047. doi: 10.1084\/jem.20161802","journal-title":"J Exp Med"},{"issue":"12","key":"2635_CR4","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1056\/NEJMra021405","volume":"348","author":"L Taupenot","year":"2003","unstructured":"Taupenot L, Harper KL, O\u2019Connor DT (2003) The chromogranin-secretogranin family. N Engl J Med 348(12):1134\u20131149. doi: 10.1056\/NEJMra021405","journal-title":"N Engl J Med"},{"issue":"4","key":"2635_CR5","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1017\/S146479310400644X","volume":"79","author":"KB Helle","year":"2004","unstructured":"Helle KB (2004) The granin family of uniquely acidic proteins of the diffuse neuroendocrine system: comparative and functional aspects. Biol Rev Camb Philos Soc 79(4):769\u2013794","journal-title":"Biol Rev Camb Philos Soc"},{"issue":"6","key":"2635_CR6","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1210\/er.2010-0027","volume":"32","author":"A Bartolomucci","year":"2011","unstructured":"Bartolomucci A, Possenti R, Mahata SK, Fischer-Colbrie R, Loh YP, Salton SR (2011) The extended granin family: structure, function, and biomedical implications. Endocr Rev 32(6):755\u2013797. doi: 10.1210\/er.2010-0027","journal-title":"Endocr Rev"},{"issue":"2","key":"2635_CR7","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s00018-014-1750-9","volume":"72","author":"KB Helle","year":"2015","unstructured":"Helle KB, Corti A (2015) Chromogranin A: a paradoxical player in angiogenesis and vascular biology. Cell Mol Life Sci 72(2):339\u2013348. doi: 10.1007\/s00018-014-1750-9","journal-title":"Cell Mol Life Sci"},{"issue":"11","key":"2635_CR8","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/0306-4522(80)90031-7","volume":"5","author":"H Winkler","year":"1980","unstructured":"Winkler H, Westhead E (1980) The molecular organization of adrenal chromaffin granules. Neuroscience 5(11):1803\u20131823","journal-title":"Neuroscience"},{"key":"2635_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/0-306-46837-9_1","volume":"482","author":"KB Helle","year":"2000","unstructured":"Helle KB (2000) The chromogranins. Historical perspectives. Adv Exp Med Biol 482:3\u201320. doi: 10.1007\/0-306-46837-9_1","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"2635_CR10","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/0306-4522(92)90222-N","volume":"49","author":"H Winkler","year":"1992","unstructured":"Winkler H, Fischer-Colbrie R (1992) The chromogranins A and B: the first 25\u00a0years and future perspectives. Neuroscience 49(3):497\u2013528","journal-title":"Neuroscience"},{"issue":"5","key":"2635_CR11","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1016\/S0021-9258(17)43286-8","volume":"259","author":"DT O\u2019Connor","year":"1984","unstructured":"O\u2019Connor DT, Frigon RP (1984) Chromogranin A, the major catecholamine storage vesicle soluble protein. Multiple size forms, subcellular storage, and regional distribution in chromaffin and nervous tissue elucidated by radioimmunoassay. J Biol Chem 259(5):3237\u20133247","journal-title":"J Biol Chem"},{"issue":"4","key":"2635_CR12","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1507\/endocrj.K10E-038","volume":"57","author":"M Hosaka","year":"2010","unstructured":"Hosaka M, Watanabe T (2010) Secretogranin III: a bridge between core hormone aggregates and the secretory granule membrane. Endocr J 57(4):275\u2013286","journal-title":"Endocr J"},{"issue":"2","key":"2635_CR13","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/BF01606581","volume":"423","author":"N Neuhold","year":"1993","unstructured":"Neuhold N, Ullrich R (1993) Secretogranin IV immunoreactivity in medullary thyroid carcinoma: an immunohistochemical study of 62 cases. Virchows Arch A Pathol Anat Histopathol 423(2):85\u201389","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"issue":"4721","key":"2635_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1126\/science.2994224","volume":"230","author":"RB Kelly","year":"1985","unstructured":"Kelly RB (1985) Pathways of protein secretion in eukaryotes. Science 230(4721):25\u201332","journal-title":"Science"},{"issue":"2","key":"2635_CR15","doi-asserted-by":"publisher","first-page":"R45","DOI":"10.1530\/EC-14-0027","volume":"3","author":"MA D\u2019Amico","year":"2014","unstructured":"D\u2019Amico MA, Ghinassi B, Izzicupo P, Manzoli L, Di Baldassarre A (2014) Biological function and clinical relevance of chromogranin A and derived peptides. Endocr Connect 3(2):R45\u2013R54. doi: 10.1530\/EC-14-0027","journal-title":"Endocr Connect"},{"issue":"6","key":"2635_CR16","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.peptides.2011.03.011","volume":"32","author":"K Lorenz","year":"2011","unstructured":"Lorenz K, Troger J, Gramlich O, Grus F, Hattmannstorfer R, Fischer-Colbrie R et al (2011) PE-11, a peptide derived from chromogranin B, in the rat eye. Peptides 32(6):1201\u20131206. doi: 10.1016\/j.peptides.2011.03.011","journal-title":"Peptides"},{"issue":"2","key":"2635_CR17","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/j.1432-1033.1995.tb20476.x","volume":"229","author":"JM Strub","year":"1995","unstructured":"Strub JM, Garcia-Sablone P, Lonning K, Taupenot L, Hubert P, Van Dorsselaer A et al (1995) Processing of chromogranin B in bovine adrenal medulla. Identification of secretolytin, the endogenous C-terminal fragment of residues 614\u2013626 with antibacterial activity. Eur J Biochem 229(2):356\u2013368","journal-title":"Eur J Biochem"},{"issue":"4","key":"2635_CR18","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/BF00712845","volume":"10","author":"T Flanagan","year":"1990","unstructured":"Flanagan T, Taylor L, Poulter L, Viveros OH, Diliberto EJ Jr (1990) A novel 1745-dalton pyroglutamyl peptide derived from chromogranin B is in the bovine adrenomedullary chromaffin vesicle. Cell Mol Neurobiol 10(4):507\u2013523","journal-title":"Cell Mol Neurobiol"},{"issue":"9","key":"2635_CR19","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1161\/01.CIR.0000139884.81390.56","volume":"110","author":"R Kirchmair","year":"2004","unstructured":"Kirchmair R, Egger M, Walter DH, Eisterer W, Niederwanger A, Woell E et al (2004) Secretoneurin, an angiogenic neuropeptide, induces postnatal vasculogenesis. Circulation 110(9):1121\u20131127. doi: 10.1161\/01.CIR.0000139884.81390.56","journal-title":"Circulation"},{"issue":"30","key":"2635_CR20","doi-asserted-by":"publisher","first-page":"17755","DOI":"10.1074\/jbc.271.30.17755","volume":"271","author":"JC Holthuis","year":"1996","unstructured":"Holthuis JC, Jansen EJ, Martens GJ (1996) Secretogranin III is a sulfated protein undergoing proteolytic processing in the regulated secretory pathway. J Biol Chem 271(30):17755\u201317760","journal-title":"J Biol Chem"},{"issue":"20","key":"2635_CR21","doi-asserted-by":"publisher","first-page":"4141","DOI":"10.1002\/elps.200800152","volume":"29","author":"P Dowling","year":"2008","unstructured":"Dowling P, Shields W, Rani S, Meleady P, Henry M, Jeppesen P et al (2008) Proteomic analysis of conditioned media from glucose responsive and glucose non-responsive phenotypes reveals a panel of secreted proteins associated with beta cell dysfunction. Electrophoresis 29(20):4141\u20134149","journal-title":"Electrophoresis"},{"issue":"4","key":"2635_CR22","first-page":"411","volume":"34","author":"YP Rong","year":"2002","unstructured":"Rong YP, Liu F, Zeng LC, Ma WJ, Wei DZ, Han ZG (2002) Cloning and characterization of a novel human secretory protein: secretogranin III. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 34(4):411\u2013417","journal-title":"Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai)"},{"issue":"10","key":"2635_CR23","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1055\/s-2007-1003361","volume":"24","author":"V Sanchez-Margalet","year":"1992","unstructured":"Sanchez-Margalet V, Calvo JR, Goberna R (1992) Glucogenolytic and hyperglycemic effect of 33\u201349 C-terminal fragment of pancreastatin in the rat in vivo. Horm Metab Res 24(10):455\u2013457","journal-title":"Horm Metab Res"},{"issue":"6096","key":"2635_CR24","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/324476a0","volume":"324","author":"K Tatemoto","year":"1986","unstructured":"Tatemoto K, Efendic S, Mutt V, Makk G, Feistner GJ, Barchas JD (1986) Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion. Nature 324(6096):476\u2013478. doi: 10.1038\/324476a0","journal-title":"Nature"},{"issue":"8","key":"2635_CR25","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.2337\/diabetes.49.8.1288","volume":"49","author":"C Gonzalez-Yanes","year":"2000","unstructured":"Gonzalez-Yanes C, Sanchez-Margalet V (2000) Pancreastatin modulates insulin signaling in rat adipocytes: mechanisms of cross-talk. Diabetes 49(8):1288\u20131294","journal-title":"Diabetes"},{"issue":"42","key":"2635_CR26","doi-asserted-by":"publisher","first-page":"28498","DOI":"10.1074\/jbc.M109.020636","volume":"284","author":"JR Gayen","year":"2009","unstructured":"Gayen JR, Saberi M, Schenk S, Biswas N, Vaingankar SM, Cheung WW et al (2009) A novel pathway of insulin sensitivity in chromogranin A null mice: a crucial role for pancreastatin in glucose homeostasis. J Biol Chem 284(42):28498\u201328509. doi: 10.1074\/jbc.M109.020636","journal-title":"J Biol Chem"},{"issue":"9","key":"2635_CR27","doi-asserted-by":"publisher","first-page":"5414","DOI":"10.1210\/jc.2005-0408","volume":"90","author":"DT O\u2019Connor","year":"2005","unstructured":"O\u2019Connor DT, Cadman PE, Smiley C, Salem RM, Rao F, Smith J et al (2005) Pancreastatin: multiple actions on human intermediary metabolism in vivo, variation in disease, and naturally occurring functional genetic polymorphism. J Clin Endocrinol Metab 90(9):5414\u20135425. doi: 10.1210\/jc.2005-0408","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2635_CR28","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1172\/JCI119686","volume":"100","author":"SK Mahata","year":"1997","unstructured":"Mahata SK, O\u2019Connor DT, Mahata M, Yoo SH, Taupenot L, Wu H et al (1997) Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist. J Clin Investig 100(6):1623\u20131633. doi: 10.1172\/JCI119686","journal-title":"J Clin Investig"},{"issue":"7","key":"2635_CR29","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/S0196-9781(98)00086-2","volume":"19","author":"BP Kennedy","year":"1998","unstructured":"Kennedy BP, Mahata SK, O\u2019Connor DT, Ziegler MG (1998) Mechanism of cardiovascular actions of the chromogranin A fragment catestatin in vivo. Peptides 19(7):1241\u20131248","journal-title":"Peptides"},{"issue":"1\u20133","key":"2635_CR30","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ejphar.2008.09.016","volume":"598","author":"M Egger","year":"2008","unstructured":"Egger M, Beer AG, Theurl M, Schgoer W, Hotter B, Tatarczyk T et al (2008) Monocyte migration: a novel effect and signaling pathways of catestatin. Eur J Pharmacol 598(1\u20133):104\u2013111. doi: 10.1016\/j.ejphar.2008.09.016","journal-title":"Eur J Pharmacol"},{"issue":"24","key":"2635_CR31","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.2174\/092986712802430063","volume":"19","author":"R Aslam","year":"2012","unstructured":"Aslam R, Atindehou M, Lavaux T, Haikel Y, Schneider F, Metz-Boutigue MH (2012) Chromogranin A-derived peptides are involved in innate immunity. Curr Med Chem 19(24):4115\u20134123","journal-title":"Curr Med Chem"},{"issue":"7","key":"2635_CR32","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/00004872-200207000-00020","volume":"20","author":"DT O\u2019Connor","year":"2002","unstructured":"O\u2019Connor DT, Kailasam MT, Kennedy BP, Ziegler MG, Yanaihara N, Parmer RJ (2002) Early decline in the catecholamine release-inhibitory peptide catestatin in humans at genetic risk of hypertension. J Hypertens 20(7):1335\u20131345","journal-title":"J Hypertens"},{"issue":"1","key":"2635_CR33","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1161\/01.HYP.26.1.213","volume":"26","author":"MA Takiyyuddin","year":"1995","unstructured":"Takiyyuddin MA, Parmer RJ, Kailasam MT, Cervenka JH, Kennedy B, Ziegler MG et al (1995) Chromogranin A in human hypertension. Influence of heredity. Hypertension 26(1):213\u2013220","journal-title":"Hypertension"},{"issue":"6","key":"2635_CR34","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/BF00166897","volume":"354","author":"ZB You","year":"1996","unstructured":"You ZB, Saria A, Fischer-Colbrie R, Terenius L, Goiny M, Herrera-Marschitz M (1996) Effects of secretogranin II-derived peptides on the release of neurotransmitters monitored in the basal ganglia of the rat with in vivo microdialysis. Naunyn Schmiedebergs Arch Pharmacol 354(6):717\u2013724","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"5","key":"2635_CR35","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1210\/en.2008-1060","volume":"150","author":"E Zhao","year":"2009","unstructured":"Zhao E, Basak A, Wong AO, Ko W, Chen A, Lopez GC et al (2009) The secretogranin II-derived peptide secretoneurin stimulates luteinizing hormone secretion from gonadotrophs. Endocrinology 150(5):2273\u20132282. doi: 10.1210\/en.2008-1060","journal-title":"Endocrinology"},{"issue":"1","key":"2635_CR36","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0301-0082(94)00060-U","volume":"46","author":"R Fischer-Colbrie","year":"1995","unstructured":"Fischer-Colbrie R, Laslop A, Kirchmair R (1995) Secretogranin II: molecular properties, regulation of biosynthesis and processing to the neuropeptide secretoneurin. Prog Neurobiol 46(1):49\u201370","journal-title":"Prog Neurobiol"},{"issue":"3","key":"2635_CR37","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/0306-4522(95)00476-9","volume":"71","author":"MK Storch","year":"1996","unstructured":"Storch MK, Fischer-Colbrie R, Smith T, Rinner WA, Hickey WF, Cuzner ML et al (1996) Co-localization of secretoneurin immunoreactivity and macrophage infiltration in the lesions of experimental autoimmune encephalomyelitis. Neuroscience 71(3):885\u2013893","journal-title":"Neuroscience"},{"issue":"3","key":"2635_CR38","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0896-6273(00)80806-5","volume":"23","author":"S Hahm","year":"1999","unstructured":"Hahm S, Mizuno TM, Wu TJ, Wisor JP, Priest CA, Kozak CA et al (1999) Targeted deletion of the Vgf gene indicates that the encoded secretory peptide precursor plays a novel role in the regulation of energy balance. Neuron 23(3):537\u2013548","journal-title":"Neuron"},{"key":"2635_CR39","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1472-6793-9-19","volume":"9","author":"E Watson","year":"2009","unstructured":"Watson E, Fargali S, Okamoto H, Sadahiro M, Gordon RE, Chakraborty T et al (2009) Analysis of knockout mice suggests a role for VGF in the control of fat storage and energy expenditure. BMC Physiol 9:19. doi: 10.1186\/1472-6793-9-19","journal-title":"BMC Physiol"},{"issue":"12","key":"2635_CR40","doi-asserted-by":"publisher","first-page":"5151","DOI":"10.1210\/en.2005-0588","volume":"146","author":"E Watson","year":"2005","unstructured":"Watson E, Hahm S, Mizuno TM, Windsor J, Montgomery C, Scherer PE et al (2005) VGF ablation blocks the development of hyperinsulinemia and hyperglycemia in several mouse models of obesity. Endocrinology 146(12):5151\u20135163. doi: 10.1210\/en.2005-0588","journal-title":"Endocrinology"},{"issue":"39","key":"2635_CR41","doi-asserted-by":"publisher","first-page":"14584","DOI":"10.1073\/pnas.0606102103","volume":"103","author":"A Bartolomucci","year":"2006","unstructured":"Bartolomucci A, La Corte G, Possenti R, Locatelli V, Rigamonti AE, Torsello A et al (2006) TLQP-21, a VGF-derived peptide, increases energy expenditure and prevents the early phase of diet-induced obesity. Proc Natl Acad Sci USA 103(39):14584\u201314589. doi: 10.1073\/pnas.0606102103","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2635_CR42","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s12263-009-0110-0","volume":"4","author":"A Bartolomucci","year":"2009","unstructured":"Bartolomucci A, Bresciani E, Bulgarelli I, Rigamonti AE, Pascucci T, Levi A et al (2009) Chronic intracerebroventricular injection of TLQP-21 prevents high fat diet induced weight gain in fast weight-gaining mice. Genes Nutr 4(1):49\u201357. doi: 10.1007\/s12263-009-0110-0","journal-title":"Genes Nutr"},{"issue":"4","key":"2635_CR43","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1007\/s00726-010-0818-6","volume":"42","author":"V Sibilia","year":"2012","unstructured":"Sibilia V, Pagani F, Bulgarelli I, Tulipano G, Possenti R, Guidobono F (2012) Characterization of the mechanisms involved in the gastric antisecretory effect of TLQP-21, a vgf-derived peptide, in rats. Amino Acids 42(4):1261\u20131268. doi: 10.1007\/s00726-010-0818-6","journal-title":"Amino Acids"},{"issue":"6","key":"2635_CR44","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1111\/j.1476-5381.2009.00192.x","volume":"157","author":"C Severini","year":"2009","unstructured":"Severini C, La Corte G, Improta G, Broccardo M, Agostini S, Petrella C et al (2009) In vitro and in vivo pharmacological role of TLQP-21, a VGF-derived peptide, in the regulation of rat gastric motor functions. Br J Pharmacol 157(6):984\u2013993. doi: 10.1111\/j.1476-5381.2009.00192.x","journal-title":"Br J Pharmacol"},{"issue":"3","key":"2635_CR45","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1159\/000319791","volume":"92","author":"V Sibilia","year":"2010","unstructured":"Sibilia V, Pagani F, Bulgarelli I, Mrak E, Broccardo M, Improta G et al (2010) TLQP-21, a VGF-derived peptide, prevents ethanol-induced gastric lesions: insights into its mode of action. Neuroendocrinology 92(3):189\u2013197. doi: 10.1159\/000319791","journal-title":"Neuroendocrinology"},{"issue":"39","key":"2635_CR46","doi-asserted-by":"publisher","first-page":"9857","DOI":"10.1523\/JNEUROSCI.3145-08.2008","volume":"28","author":"O Bozdagi","year":"2008","unstructured":"Bozdagi O, Rich E, Tronel S, Sadahiro M, Patterson K, Shapiro ML et al (2008) The neurotrophin-inducible gene Vgf regulates hippocampal function and behavior through a brain-derived neurotrophic factor-dependent mechanism. J Neurosci 28(39):9857\u20139869. doi: 10.1523\/JNEUROSCI.3145-08.2008","journal-title":"J Neurosci"},{"issue":"3","key":"2635_CR47","doi-asserted-by":"publisher","first-page":"E394","DOI":"10.1152\/ajpendo.00768.2009","volume":"299","author":"K Toshinai","year":"2010","unstructured":"Toshinai K, Yamaguchi H, Kageyama H, Matsuo T, Koshinaka K, Sasaki K et al (2010) Neuroendocrine regulatory peptide-2 regulates feeding behavior via the orexin system in the hypothalamus. Am J Physiol Endocrinol Metab 299(3):E394\u2013E401. doi: 10.1152\/ajpendo.00768.2009","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"36","key":"2635_CR48","doi-asserted-by":"publisher","first-page":"26354","DOI":"10.1074\/jbc.M701665200","volume":"282","author":"H Yamaguchi","year":"2007","unstructured":"Yamaguchi H, Sasaki K, Satomi Y, Shimbara T, Kageyama H, Mondal MS et al (2007) Peptidomic identification and biological validation of neuroendocrine regulatory peptide-1 and -2. J Biol Chem 282(36):26354\u201326360. doi: 10.1074\/jbc.M701665200","journal-title":"J Biol Chem"},{"issue":"1\u20132","key":"2635_CR49","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/0169-328X(92)90053-E","volume":"13","author":"GL Ferri","year":"1992","unstructured":"Ferri GL, Levi A, Possenti R (1992) A novel neuroendocrine gene product: selective VGF8a gene expression and immuno-localisation of the VGF protein in endocrine and neuronal populations. Brain Res Mol Brain Res 13(1\u20132):139\u2013143","journal-title":"Brain Res Mol Brain Res"},{"key":"2635_CR50","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1744-8069-4-62","volume":"4","author":"A Moss","year":"2008","unstructured":"Moss A, Ingram R, Koch S, Theodorou A, Low L, Baccei M et al (2008) Origins, actions and dynamic expression patterns of the neuropeptide VGF in rat peripheral and central sensory neurones following peripheral nerve injury. Mol Pain 4:62. doi: 10.1186\/1744-8069-4-62","journal-title":"Mol Pain"},{"key":"2635_CR51","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1471-2202-3-16","volume":"3","author":"M Costigan","year":"2002","unstructured":"Costigan M, Befort K, Karchewski L, Griffin RS, D\u2019Urso D, Allchorne A et al (2002) Replicate high-density rat genome oligonucleotide microarrays reveal hundreds of regulated genes in the dorsal root ganglion after peripheral nerve injury. BMC Neurosci 3:16","journal-title":"BMC Neurosci"},{"issue":"42","key":"2635_CR52","doi-asserted-by":"publisher","first-page":"13377","DOI":"10.1523\/JNEUROSCI.1127-09.2009","volume":"29","author":"MS Riedl","year":"2009","unstructured":"Riedl MS, Braun PD, Kitto KF, Roiko SA, Anderson LB, Honda CN et al (2009) Proteomic analysis uncovers novel actions of the neurosecretory protein VGF in nociceptive processing. J Neurosci 29(42):13377\u201313388. doi: 10.1523\/JNEUROSCI.1127-09.2009","journal-title":"J Neurosci"},{"issue":"1","key":"2635_CR53","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.neulet.2008.06.018","volume":"441","author":"R Rizzi","year":"2008","unstructured":"Rizzi R, Bartolomucci A, Moles A, D\u2019Amato F, Sacerdote P, Levi A et al (2008) The VGF-derived peptide TLQP-21: a new modulatory peptide for inflammatory pain. Neurosci Lett 441(1):129\u2013133. doi: 10.1016\/j.neulet.2008.06.018","journal-title":"Neurosci Lett"},{"issue":"12","key":"2635_CR54","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1038\/nm1669","volume":"13","author":"JG Hunsberger","year":"2007","unstructured":"Hunsberger JG, Newton SS, Bennett AH, Duman CH, Russell DS, Salton SR et al (2007) Antidepressant actions of the exercise-regulated gene VGF. Nat Med 13(12):1476\u20131482. doi: 10.1038\/nm1669","journal-title":"Nat Med"},{"issue":"45","key":"2635_CR55","doi-asserted-by":"publisher","first-page":"12156","DOI":"10.1523\/JNEUROSCI.1898-07.2007","volume":"27","author":"S Thakker-Varia","year":"2007","unstructured":"Thakker-Varia S, Krol JJ, Nettleton J, Bilimoria PM, Bangasser DA, Shors TJ et al (2007) The neuropeptide VGF produces antidepressant-like behavioral effects and enhances proliferation in the hippocampus. J Neurosci 27(45):12156\u201312167. doi: 10.1523\/JNEUROSCI.1898-07.2007","journal-title":"J Neurosci"},{"issue":"11","key":"2635_CR56","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1111\/j.1460-9568.2004.03781.x","volume":"20","author":"S Succu","year":"2004","unstructured":"Succu S, Cocco C, Mascia MS, Melis T, Melis MR, Possenti R et al (2004) Pro-VGF-derived peptides induce penile erection in male rats: possible involvement of oxytocin. Eur J Neurosci 20(11):3035\u20133040. doi: 10.1111\/j.1460-9568.2004.03781.x","journal-title":"Eur J Neurosci"},{"issue":"7","key":"2635_CR57","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.neuropharm.2005.05.015","volume":"49","author":"S Succu","year":"2005","unstructured":"Succu S, Mascia MS, Melis T, Sanna F, Melis MR, Possenti R et al (2005) Pro-VGF-derived peptides induce penile erection in male rats: involvement of paraventricular nitric oxide. Neuropharmacology 49(7):1017\u20131025. doi: 10.1016\/j.neuropharm.2005.05.015","journal-title":"Neuropharmacology"},{"issue":"8","key":"2635_CR58","doi-asserted-by":"publisher","first-page":"4116","DOI":"10.1210\/en.2008-0064","volume":"149","author":"SN Lee","year":"2008","unstructured":"Lee SN, Lindberg I (2008) 7B2 prevents unfolding and aggregation of prohormone convertase 2. Endocrinology 149(8):4116\u20134127. doi: 10.1210\/en.2008-0064","journal-title":"Endocrinology"},{"issue":"31","key":"2635_CR59","doi-asserted-by":"publisher","first-page":"23596","DOI":"10.1074\/jbc.M001583200","volume":"275","author":"Y Qian","year":"2000","unstructured":"Qian Y, Devi LA, Mzhavia N, Munzer S, Seidah NG, Fricker LD (2000) The C-terminal region of proSAAS is a potent inhibitor of prohormone convertase 1. J Biol Chem 275(31):23596\u201323601. doi: 10.1074\/jbc.M001583200","journal-title":"J Biol Chem"},{"issue":"6","key":"2635_CR60","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1046\/j.1471-4159.1996.66062248.x","volume":"66","author":"JC Holthuis","year":"1996","unstructured":"Holthuis JC, Martens GJ (1996) The neuroendocrine proteins secretogranin II and III are regionally conserved and coordinately expressed with proopiomelanocortin in Xenopus intermediate pituitary. J Neurochem 66(6):2248\u20132256","journal-title":"J Neurochem"},{"issue":"10","key":"2635_CR61","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1091\/mbc.02-03-0040","volume":"13","author":"M Hosaka","year":"2002","unstructured":"Hosaka M, Watanabe T, Sakai Y, Uchiyama Y, Takeuchi T (2002) Identification of a chromogranin A domain that mediates binding to secretogranin III and targeting to secretory granules in pituitary cells and pancreatic beta-cells. Mol Biol Cell 13(10):3388\u20133399. doi: 10.1091\/mbc.02-03-0040","journal-title":"Mol Biol Cell"},{"issue":"5","key":"2635_CR62","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1074\/jbc.M310104200","volume":"279","author":"M Hosaka","year":"2004","unstructured":"Hosaka M, Suda M, Sakai Y, Izumi T, Watanabe T, Takeuchi T (2004) Secretogranin III binds to cholesterol in the secretory granule membrane as an adapter for chromogranin A. J Biol Chem 279(5):3627\u20133634. doi: 10.1074\/jbc.M310104200 PubMed PMID: 14597614","journal-title":"J Biol Chem"},{"issue":"Pt 20","key":"2635_CR63","doi-asserted-by":"publisher","first-page":"4785","DOI":"10.1242\/jcs.02608","volume":"118","author":"M Hosaka","year":"2005","unstructured":"Hosaka M, Watanabe T, Sakai Y, Kato T, Takeuchi T (2005) Interaction between secretogranin III and carboxypeptidase E facilitates prohormone sorting within secretory granules. J Cell Sci 118(Pt 20):4785\u20134795. doi: 10.1242\/jcs.02608","journal-title":"J Cell Sci"},{"issue":"3","key":"2635_CR64","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1210\/jc.2006-1808","volume":"92","author":"A Tanabe","year":"2007","unstructured":"Tanabe A, Yanagiya T, Iida A, Saito S, Sekine A, Takahashi A et al (2007) Functional single-nucleotide polymorphisms in the secretogranin III (SCG3) gene that form secretory granules with appetite-related neuropeptides are associated with obesity. J Clin Endocrinol Metab 92(3):1145\u20131154. doi: 10.1210\/jc.2006-1808","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2635_CR65","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/j.1460-2075.1990.tb08123.x","volume":"9","author":"DM Kingsley","year":"1990","unstructured":"Kingsley DM, Rinchik EM, Russell LB, Ottiger HP, Sutcliffe JG, Copeland NG et al (1990) Genetic ablation of a mouse gene expressed specifically in brain. EMBO J 9(2):395\u2013399","journal-title":"EMBO J"},{"issue":"5","key":"2635_CR66","doi-asserted-by":"publisher","first-page":"e0127904","DOI":"10.1371\/journal.pone.0127904","volume":"10","author":"ME LeBlanc","year":"2015","unstructured":"LeBlanc ME, Wang W, Caberoy NB, Chen X, Guo F, Alvarado G et al (2015) Hepatoma-derived growth factor-related protein-3 is a novel angiogenic factor. PLoS One 10(5):e0127904","journal-title":"PLoS One"},{"issue":"12","key":"2635_CR67","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1091\/mbc.E14-09-1343","volume":"26","author":"F Guo","year":"2015","unstructured":"Guo F, Ding Y, Caberoy N, Alvarado G, Wang F, Chen R et al (2015) ABCF1 extrinsically regulates retinal pigment epithelial cell phagocytosis. Mol Biol Cell 26(12):2311\u20132320","journal-title":"Mol Biol Cell"},{"issue":"5","key":"2635_CR68","doi-asserted-by":"publisher","first-page":"e0126993","DOI":"10.1371\/journal.pone.0126993","volume":"10","author":"Y Ding","year":"2015","unstructured":"Ding Y, Caberoy NB, Guo F, LeBlanc ME, Zhang C, Wang W et al (2015) Reticulocalbin-1 facilitates microglial phagocytosis. PLoS One 10(5):e0126993","journal-title":"PLoS One"},{"key":"2635_CR69","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3389\/fchem.2014.00064","volume":"2","author":"B Tota","year":"2014","unstructured":"Tota B, Angelone T, Cerra MC (2014) The surging role of chromogranin A in cardiovascular homeostasis. Front Chem 2:64. doi: 10.3389\/fchem.2014.00064","journal-title":"Front Chem"},{"issue":"2","key":"2635_CR70","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1182\/blood-2012-05-430314","volume":"121","author":"L Crippa","year":"2013","unstructured":"Crippa L, Bianco M, Colombo B, Gasparri AM, Ferrero E, Loh YP et al (2013) A new chromogranin A-dependent angiogenic switch activated by thrombin. Blood 121(2):392\u2013402. doi: 10.1182\/blood-2012-05-430314","journal-title":"Blood"},{"issue":"3","key":"2635_CR71","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1096\/fj.03-0922fje","volume":"18","author":"E Ferrero","year":"2004","unstructured":"Ferrero E, Scabini S, Magni E, Foglieni C, Belloni D, Colombo B et al (2004) Chromogranin A protects vessels against tumor necrosis factor alpha-induced vascular leakage. FASEB J 18(3):554\u2013556. doi: 10.1096\/fj.03-0922fje","journal-title":"FASEB J"},{"issue":"1\u20132","key":"2635_CR72","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.regpep.2006.04.007","volume":"135","author":"A Blois","year":"2006","unstructured":"Blois A, Srebro B, Mandala M, Corti A, Helle KB, Serck-Hanssen G (2006) The chromogranin A peptide vasostatin-I inhibits gap formation and signal transduction mediated by inflammatory agents in cultured bovine pulmonary and coronary arterial endothelial cells. Regul Pept 135(1\u20132):78\u201384. doi: 10.1016\/j.regpep.2006.04.007","journal-title":"Regul Pept"},{"issue":"11","key":"2635_CR73","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1161\/CIRCRESAHA.110.219493","volume":"107","author":"M Theurl","year":"2010","unstructured":"Theurl M, Schgoer W, Albrecht K, Jeschke J, Egger M, Beer AG et al (2010) The neuropeptide catestatin acts as a novel angiogenic cytokine via a basic fibroblast growth factor-dependent mechanism. Circ Res 107(11):1326\u20131335. doi: 10.1161\/CIRCRESAHA.110.219493","journal-title":"Circ Res"},{"issue":"11","key":"2635_CR74","first-page":"914","volume":"40","author":"L Ji","year":"2012","unstructured":"Ji L, Pei ZQ, Ma DF, Zhang J, Su JS, Gao XD et al (2012) Prognostic value of circulating catestatin levels for in-hospital heart failure in patients with acute myocardial infarction. Zhonghua Xin Xue Guan Bing Za Zhi 40(11):914\u2013919","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"issue":"89","key":"2635_CR75","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1136\/postgradmedj-2012-131060","volume":"2013","author":"L Meng","year":"1050","unstructured":"Meng L, Wang J, Ding WH, Han P, Yang Y, Qi LT et al (1050) Plasma catestatin level in patients with acute myocardial infarction and its correlation with ventricular remodelling. Postgrad Med J 2013(89):193\u2013196. doi: 10.1136\/postgradmedj-2012-131060","journal-title":"Postgrad Med J"},{"issue":"6","key":"2635_CR76","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1161\/01.CIR.0000112574.07422.C1","volume":"109","author":"R Kirchmair","year":"2004","unstructured":"Kirchmair R, Gander R, Egger M, Hanley A, Silver M, Ritsch A et al (2004) The neuropeptide secretoneurin acts as a direct angiogenic cytokine in vitro and in vivo. Circulation 109(6):777\u2013783","journal-title":"Circulation"},{"issue":"21","key":"2635_CR77","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1161\/CIRCULATIONAHA.111.076950","volume":"126","author":"K Albrecht-Schgoer","year":"2012","unstructured":"Albrecht-Schgoer K, Schgoer W, Holfeld J, Theurl M, Wiedemann D, Steger C et al (2012) The angiogenic factor secretoneurin induces coronary angiogenesis in a model of myocardial infarction by stimulation of vascular endothelial growth factor signaling in endothelial cells. Circulation 126(21):2491\u20132501. doi: 10.1161\/CIRCULATIONAHA.111.076950","journal-title":"Circulation"},{"issue":"3","key":"2635_CR78","doi-asserted-by":"publisher","first-page":"556","DOI":"10.2337\/dc11-1909","volume":"35","author":"JW Yau","year":"2012","unstructured":"Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T et al (2012) Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 35(3):556\u2013564","journal-title":"Diabetes Care"},{"key":"2635_CR79","doi-asserted-by":"publisher","first-page":"16012","DOI":"10.1038\/nrdp.2016.12","volume":"2","author":"TY Wong","year":"2016","unstructured":"Wong TY, Cheung CM, Larsen M, Sharma S, Simo R (2016) Diabetic retinopathy. Nat Rev Dis Primers 2:16012. doi: 10.1038\/nrdp.2016.12","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"2635_CR80","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1073\/pnas.022644499","volume":"99","author":"K Suzuma","year":"2002","unstructured":"Suzuma K, Takahara N, Suzuma I, Isshiki K, Ueki K, Leitges M et al (2002) Characterization of protein kinase C beta isoform\u2019s action on retinoblastoma protein phosphorylation, vascular endothelial growth factor-induced endothelial cell proliferation, and retinal neovascularization. Proc Natl Acad Sci USA 99(2):721\u2013726. doi: 10.1073\/pnas.022644499","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"2635_CR81","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1038\/nm.2052","volume":"15","author":"P Geraldes","year":"2009","unstructured":"Geraldes P, Hiraoka-Yamamoto J, Matsumoto M, Clermont A, Leitges M, Marette A et al (2009) Activation of PKC-delta and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy. Nat Med 15(11):1298\u20131306. doi: 10.1038\/nm.2052","journal-title":"Nat Med"},{"issue":"11","key":"2635_CR82","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.2337\/db06-0895","volume":"55","author":"Y Ohshiro","year":"2006","unstructured":"Ohshiro Y, Ma RC, Yasuda Y, Hiraoka-Yamamoto J, Clermont AC, Isshiki K et al (2006) Reduction of diabetes-induced oxidative stress, fibrotic cytokine expression, and renal dysfunction in protein kinase Cbeta-null mice. Diabetes 55(11):3112\u20133120. doi: 10.2337\/db06-0895","journal-title":"Diabetes"},{"issue":"4","key":"2635_CR83","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1096\/fj.08-120345","volume":"23","author":"E Harja","year":"2009","unstructured":"Harja E, Chang JS, Lu Y, Leitges M, Zou YS, Schmidt AM et al (2009) Mice deficient in PKCbeta and apolipoprotein E display decreased atherosclerosis. FASEB J 23(4):1081\u20131091. doi: 10.1096\/fj.08-120345","journal-title":"FASEB J"},{"issue":"9","key":"2635_CR84","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.2337\/diab.46.9.1473","volume":"46","author":"LP Aiello","year":"1997","unstructured":"Aiello LP, Bursell SE, Clermont A, Duh E, Ishii H, Takagi C et al (1997) Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor. Diabetes 46(9):1473\u20131480","journal-title":"Diabetes"},{"issue":"5262","key":"2635_CR85","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1126\/science.272.5262.728","volume":"272","author":"H Ishii","year":"1996","unstructured":"Ishii H, Jirousek MR, Koya D, Takagi C, Xia P, Clermont A et al (1996) Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor. Science 272(5262):728\u2013731","journal-title":"Science"},{"issue":"10","key":"2635_CR86","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1097\/IAE.0b013e3182111669","volume":"31","author":"LP Aiello","year":"2011","unstructured":"Aiello LP, Vignati L, Sheetz MJ, Zhi X, Girach A, Davis MD et al (2011) Oral protein kinase c beta inhibition using ruboxistaurin: efficacy, safety, and causes of vision loss among 813 patients (1,392 eyes) with diabetic retinopathy in the Protein Kinase C beta Inhibitor-Diabetic Retinopathy Study and the Protein Kinase C beta Inhibitor-Diabetic Retinopathy Study 2. Retina 31(10):2084\u20132094. doi: 10.1097\/IAE.0b013e3182111669","journal-title":"Retina"},{"issue":"11","key":"2635_CR87","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.2337\/diacare.28.11.2686","volume":"28","author":"KR Tuttle","year":"2005","unstructured":"Tuttle KR, Bakris GL, Toto RD, McGill JB, Hu K, Anderson PW (2005) The effect of ruboxistaurin on nephropathy in type 2 diabetes. Diabetes Care 28(11):2686\u20132690","journal-title":"Diabetes Care"},{"issue":"5","key":"2635_CR88","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1161\/CIRCRESAHA.109.212217","volume":"106","author":"SF Yan","year":"2010","unstructured":"Yan SF, Ramasamy R, Schmidt AM (2010) The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature. Circ Res 106(5):842\u2013853","journal-title":"Circ Res"},{"issue":"2","key":"2635_CR89","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1172\/JCI11771","volume":"108","author":"Y Yamamoto","year":"2001","unstructured":"Yamamoto Y, Kato I, Doi T, Yonekura H, Ohashi S, Takeuchi M et al (2001) Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice. J Clin Investig 108(2):261\u2013268. doi: 10.1172\/JCI11771","journal-title":"J Clin Investig"},{"issue":"9","key":"2635_CR90","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/2012","volume":"4","author":"L Park","year":"1998","unstructured":"Park L, Raman KG, Lee KJ, Lu Y, Ferran LJ Jr, Chow WS et al (1998) Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat Med 4(9):1025\u20131031","journal-title":"Nat Med"},{"issue":"6865","key":"2635_CR91","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/414813a","volume":"414","author":"M Brownlee","year":"2001","unstructured":"Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414(6865):813\u2013820. doi: 10.1038\/414813a","journal-title":"Nature"},{"issue":"2","key":"2635_CR92","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1096\/fj.09-135731","volume":"24","author":"Y Xu","year":"2010","unstructured":"Xu Y, Zhang Z, Hu J, Stillman IE, Leopold JA, Handy DE et al (2010) Glucose-6-phosphate dehydrogenase-deficient mice have increased renal oxidative stress and increased albuminuria. FASEB J. 24(2):609\u2013616. doi: 10.1096\/fj.09-135731","journal-title":"FASEB J."},{"issue":"9","key":"2635_CR93","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","volume":"107","author":"F Giacco","year":"2010","unstructured":"Giacco F, Brownlee M (2010) Oxidative stress and diabetic complications. Circ Res 107(9):1058\u20131070. doi: 10.1161\/CIRCRESAHA.110.223545","journal-title":"Circ Res"},{"issue":"10","key":"2635_CR94","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1161\/CIRCRESAHA.111.243972","volume":"110","author":"B Lassegue","year":"2012","unstructured":"Lassegue B, San Martin A, Griendling KK (2012) Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system. Circ Res 110(10):1364\u20131390. doi: 10.1161\/CIRCRESAHA.111.243972","journal-title":"Circ Res"},{"key":"2635_CR95","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.redox.2014.02.005","volume":"2","author":"R Breton-Romero","year":"2014","unstructured":"Breton-Romero R, Lamas S (2014) Hydrogen peroxide signaling in vascular endothelial cells. Redox Biol 2:529\u2013534. doi: 10.1016\/j.redox.2014.02.005","journal-title":"Redox Biol"},{"issue":"4","key":"2635_CR96","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1086\/677356","volume":"4","author":"S Sukriti","year":"2014","unstructured":"Sukriti S, Tauseef M, Yazbeck P, Mehta D (2014) Mechanisms regulating endothelial permeability. Pulm Circ 4(4):535\u2013551. doi: 10.1086\/677356","journal-title":"Pulm Circ"},{"issue":"8","key":"2635_CR97","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.2337\/db15-1594","volume":"65","author":"YJ Lee","year":"2016","unstructured":"Lee YJ, Jung SH, Kim SH, Kim MS, Lee S, Hwang J et al (2016) Essential role of transglutaminase 2 in vascular endothelial growth factor-induced vascular leakage in the retina of diabetic mice. Diabetes 65(8):2414\u20132428. doi: 10.2337\/db15-1594","journal-title":"Diabetes"},{"issue":"1","key":"2635_CR98","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.devcel.2011.11.002","volume":"22","author":"XL Chen","year":"2012","unstructured":"Chen XL, Nam JO, Jean C, Lawson C, Walsh CT, Goka E et al (2012) VEGF-induced vascular permeability is mediated by FAK. Dev Cell 22(1):146\u2013157. doi: 10.1016\/j.devcel.2011.11.002","journal-title":"Dev Cell"},{"issue":"4","key":"2635_CR99","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.cmet.2013.09.003","volume":"18","author":"A Cerani","year":"2013","unstructured":"Cerani A, Tetreault N, Menard C, Lapalme E, Patel C, Sitaras N et al (2013) Neuron-derived semaphorin 3A is an early inducer of vascular permeability in diabetic retinopathy via neuropilin-1. Cell Metab 18(4):505\u2013518. doi: 10.1016\/j.cmet.2013.09.003","journal-title":"Cell Metab"},{"issue":"6","key":"2635_CR100","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1056\/NEJM200002103420603","volume":"342","author":"JM Lachin","year":"2000","unstructured":"Diabetes Control Complications Trial\/Epidemiology of Diabetes Interventions Complications Research Group, Lachin JM, Genuth S, Cleary P, Davis MD, Nathan DM (2000) Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med 342(6):381\u2013389. doi: 10.1056\/NEJM200002103420603","journal-title":"N Engl J Med"},{"issue":"25","key":"2635_CR101","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1056\/NEJMoa052187","volume":"353","author":"DM Nathan","year":"2005","unstructured":"Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ et al (2005) Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353(25):2643\u20132653. doi: 10.1056\/NEJMoa052187","journal-title":"N Engl J Med"},{"issue":"5","key":"2635_CR102","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.2337\/db08-1666","volume":"58","author":"D Brasacchio","year":"2009","unstructured":"Brasacchio D, Okabe J, Tikellis C, Balcerczyk A, George P, Baker EK et al (2009) Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail. Diabetes 58(5):1229\u20131236. doi: 10.2337\/db08-1666","journal-title":"Diabetes"},{"key":"2635_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.visres.2017.02.011","author":"RA Kowluru","year":"2017","unstructured":"Kowluru RA (2017) Diabetic retinopathy, metabolic memory and epigenetic modifications. Vis Res. doi: 10.1016\/j.visres.2017.02.011","journal-title":"Vis Res"},{"issue":"11","key":"2635_CR104","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1161\/CIRCRESAHA.116.306819","volume":"118","author":"ST Keating","year":"2016","unstructured":"Keating ST, Plutzky J, El-Osta A (2016) Epigenetic changes in diabetes and cardiovascular risk. Circ Res 118(11):1706\u20131722. doi: 10.1161\/CIRCRESAHA.116.306819","journal-title":"Circ Res"},{"issue":"6","key":"2635_CR105","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1002\/jcb.22644","volume":"110","author":"Q Zhong","year":"2010","unstructured":"Zhong Q, Kowluru RA (2010) Role of histone acetylation in the development of diabetic retinopathy and the metabolic memory phenomenon. J Cell Biochem 110(6):1306\u20131313. doi: 10.1002\/jcb.22644","journal-title":"J Cell Biochem"},{"issue":"31","key":"2635_CR106","doi-asserted-by":"publisher","first-page":"25869","DOI":"10.1074\/jbc.M112.375204","volume":"287","author":"CS Kadiyala","year":"2012","unstructured":"Kadiyala CS, Zheng L, Du Y, Yohannes E, Kao HY, Miyagi M et al (2012) Acetylation of retinal histones in diabetes increases inflammatory proteins: effects of minocycline and manipulation of histone acetyltransferase (HAT) and histone deacetylase (HDAC). J Biol Chem 287(31):25869\u201325880. doi: 10.1074\/jbc.M112.375204","journal-title":"J Biol Chem"},{"issue":"12","key":"2635_CR107","doi-asserted-by":"publisher","first-page":"e1000622","DOI":"10.1371\/journal.pcbi.1000622","volume":"5","author":"MO Stefanini","year":"2009","unstructured":"Stefanini MO, Wu FT, Mac Gabhann F, Popel AS (2009) The presence of VEGF receptors on the luminal surface of endothelial cells affects VEGF distribution and VEGF signaling. PLoS Comput Biol 5(12):e1000622. doi: 10.1371\/journal.pcbi.1000622","journal-title":"PLoS Comput Biol"},{"issue":"17","key":"2635_CR108","doi-asserted-by":"publisher","first-page":"11393","DOI":"10.1073\/pnas.172398299","volume":"99","author":"J Holash","year":"2002","unstructured":"Holash J, Davis S, Papadopoulos N, Croll SD, Ho L, Russell M et al (2002) VEGF-Trap: a VEGF blocker with potent antitumor effects. Proc Natl Acad Sci USA 99(17):11393\u201311398. doi: 10.1073\/pnas.172398299","journal-title":"Proc Natl Acad Sci USA"},{"issue":"16","key":"2635_CR109","doi-asserted-by":"publisher","first-page":"333","DOI":"10.4239\/wjd.v7.i16.333","volume":"7","author":"MW Stewart","year":"2016","unstructured":"Stewart MW (2016) Treatment of diabetic retinopathy: recent advances and unresolved challenges. World J Diabetes 7(16):333\u2013341. doi: 10.4239\/wjd.v7.i16.333","journal-title":"World J Diabetes"},{"issue":"13","key":"2635_CR110","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1056\/NEJMoa1414264","volume":"372","author":"JA Wells","year":"2015","unstructured":"Diabetic Retinopathy Clinical Research Network, Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP et al (2015) Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med 372(13):1193\u20131203","journal-title":"N Engl J Med"},{"key":"2635_CR111","doi-asserted-by":"publisher","DOI":"10.1007\/s10456-017-9557-6","author":"W Wang","year":"2017","unstructured":"Wang W, LeBlanc ME, Chen X, Chen P, Ji Y, Brewer M et al (2017) Pathogenic role and therapeutic potential of pleiotrophin in mouse models of ocular vascular disease. Angiogenesis. doi: 10.1007\/s10456-017-9557-6","journal-title":"Angiogenesis"},{"issue":"22","key":"2635_CR112","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","volume":"331","author":"LP Aiello","year":"1994","unstructured":"Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST et al (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331(22):1480\u20131487. doi: 10.1056\/NEJM199412013312203","journal-title":"N Engl J Med"},{"issue":"11","key":"2635_CR113","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1016\/j.ophtha.2008.06.025","volume":"115","author":"N Matsunaga","year":"2008","unstructured":"Matsunaga N, Chikaraishi Y, Izuta H, Ogata N, Shimazawa M, Matsumura M et al (2008) Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy. Ophthalmology 115(11):1916\u20131922. doi: 10.1016\/j.ophtha.2008.06.025","journal-title":"Ophthalmology"},{"issue":"7252","key":"2635_CR114","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nature08151","volume":"460","author":"A Takeda","year":"2009","unstructured":"Takeda A, Baffi JZ, Kleinman ME, Cho WG, Nozaki M, Yamada K et al (2009) CCR3 is a target for age-related macular degeneration diagnosis and therapy. Nature 460(7252):225\u2013230. doi: 10.1038\/nature08151","journal-title":"Nature"},{"issue":"9","key":"2635_CR115","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1016\/j.ajpath.2015.04.029","volume":"185","author":"N Nagai","year":"2015","unstructured":"Nagai N, Ju M, Izumi-Nagai K, Robbie SJ, Bainbridge JW, Gale DC et al (2015) Novel CCR3 antagonists are effective mono- and combination inhibitors of choroidal neovascular growth and vascular permeability. Am J Pathol 185(9):2534\u20132549. doi: 10.1016\/j.ajpath.2015.04.029","journal-title":"Am J Pathol"},{"issue":"2","key":"2635_CR116","doi-asserted-by":"publisher","first-page":"e17106","DOI":"10.1371\/journal.pone.0017106","volume":"6","author":"Y Li","year":"2011","unstructured":"Li Y, Huang D, Xia X, Wang Z, Luo L, Wen R (2011) CCR3 and choroidal neovascularization. PLoS One 6(2):e17106. doi: 10.1371\/journal.pone.0017106","journal-title":"PLoS One"},{"key":"2635_CR117","volume-title":"Janeway\u2019s immunobiology","author":"K Murphy","year":"2017","unstructured":"Murphy K (2017) Janeway\u2019s immunobiology, 9th edn. GS Garland Science, Taylor & Francis Group, New York","edition":"9"},{"issue":"3","key":"2635_CR118","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1073\/pnas.261462598","volume":"99","author":"AA Humbles","year":"2002","unstructured":"Humbles AA, Lu B, Friend DS, Okinaga S, Lora J, Al-Garawi A et al (2002) The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness. Proc Natl Acad Sci USA. 99(3):1479\u20131484. doi: 10.1073\/pnas.261462598","journal-title":"Proc Natl Acad Sci USA."},{"key":"2635_CR119","unstructured":"ClinicalTrial.gov. GW824575 first time in human (ClinicalTrials.gov Identifier: NCT01551771). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01551771?term=age-related+macular+degeneration+AND+CCR3&rank=1"},{"issue":"6","key":"2635_CR120","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.ccr.2007.04.017","volume":"11","author":"S Seaman","year":"2007","unstructured":"Seaman S, Stevens J, Yang MY, Logsdon D, Graff-Cherry C, St Croix B (2007) Genes that distinguish physiological and pathological angiogenesis. Cancer Cell 11(6):539\u2013554. doi: 10.1016\/j.ccr.2007.04.017","journal-title":"Cancer Cell"},{"issue":"4","key":"2635_CR121","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1172\/JCI83427","volume":"126","author":"TA Al-Hilal","year":"2016","unstructured":"Al-Hilal TA, Chung SW, Choi JU, Alam F, Park J, Kim SW et al (2016) Targeting prion-like protein doppel selectively suppresses tumor angiogenesis. J Clin Investig 126(4):1251\u20131266. doi: 10.1172\/JCI83427","journal-title":"J Clin Investig"},{"key":"2635_CR122","doi-asserted-by":"publisher","DOI":"10.2337\/db16-1035","author":"JD Lam","year":"2017","unstructured":"Lam JD, Oh DJ, Wong LL, Amarnani D, Park-Windhol C, Sanchez AV et al (2017) Identification of RUNX1 as a mediator of aberrant retinal angiogenesis. Diabetes. doi: 10.2337\/db16-1035","journal-title":"Diabetes"},{"issue":"9902","key":"2635_CR123","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/S0140-6736(13)60178-6","volume":"382","author":"A Hellstrom","year":"2013","unstructured":"Hellstrom A, Smith LE, Dammann O (2013) Retinopathy of prematurity. Lancet 382(9902):1445\u20131457. doi: 10.1016\/S0140-6736(13)60178-6","journal-title":"Lancet"},{"issue":"11","key":"2635_CR124","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/j.ophtha.2014.05.015","volume":"121","author":"D Lepore","year":"2014","unstructured":"Lepore D, Quinn GE, Molle F, Baldascino A, Orazi L, Sammartino M et al (2014) Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings. Ophthalmology 121(11):2212\u20132219. doi: 10.1016\/j.ophtha.2014.05.015","journal-title":"Ophthalmology"},{"issue":"7","key":"2635_CR125","doi-asserted-by":"publisher","first-page":"4039","DOI":"10.1167\/iovs.10-6798","volume":"52","author":"GA Lutty","year":"2011","unstructured":"Lutty GA, McLeod DS, Bhutto I, Wiegand SJ (2011) Effect of VEGF trap on normal retinal vascular development and oxygen-induced retinopathy in the dog. Investig Ophthalmol Vis Sci 52(7):4039\u20134047. doi: 10.1167\/iovs.10-6798","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"3","key":"2635_CR126","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1167\/iovs.13-13397","volume":"55","author":"CC Tokunaga","year":"2014","unstructured":"Tokunaga CC, Mitton KP, Dailey W, Massoll C, Roumayah K, Guzman E et al (2014) Effects of anti-VEGF treatment on the recovery of the developing retina following oxygen-induced retinopathy. Investig Ophthalmol Vis Sci 55(3):1884\u20131892. doi: 10.1167\/iovs.13-13397","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"6573","key":"2635_CR127","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/380439a0","volume":"380","author":"N Ferrara","year":"1996","unstructured":"Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O\u2019Shea KS et al (1996) Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380(6573):439\u2013442. doi: 10.1038\/380439a0","journal-title":"Nature"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00018-017-2635-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-017-2635-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-017-2635-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T23:48:10Z","timestamp":1659397690000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00018-017-2635-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,30]]},"references-count":127,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["2635"],"URL":"https:\/\/doi.org\/10.1007\/s00018-017-2635-5","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,30]]},"assertion":[{"value":"6 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}